FDA Inspection 1268935 — Opella Healthcare International SAS
The FDA completed an inspection of Opella Healthcare International SAS on Jan 10, 2025 in Compiegne. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jan 10, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Compiegne (France)
Additional details
Mutual Recognition Agreement (MRA)